Mr. Shamas Moheyuddin, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3120 Professional Dr, Ann Arbor, MI 48104 Phone: 734-677-6000 Fax: 734-677-2422 |
Dr. Eric Austad, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 3120 Professional Dr, Ann Arbor, MI 48104 Phone: 734-677-6000 Fax: 734-677-2422 |
News Archive
Results from two new clinical trials show that patients with diabetes and metabolic syndrome who are treated with ezetimibe (EZETROLĀ®) co-administered with a statin experience greater reductions in LDL ("bad") cholesterol, compared to patients taking a statin alone.
The Texas Health Services Authority (THSA) and the Health Information Trust Alliance (HITRUST) are announcing today a partnership to improve the protection of health information for Texas residents.
Orthovita, Inc., an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration to market Vitoss BA Bimodal Bone Graft Substitute as a non-structural bone void filler for use in the extremities, pelvis and posterolateral spine.
Looking to understand why some brain tumors with a specific mutation can start to reject drugs commonly used to treat them, CU Cancer Center member Jean Mulcahy Levy, MD, led researchers from institutions around the country -; including several from the University of Colorado School of Medicine -; to study samples of brain tumors before and after being treated with the drug.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
› Verified 7 days ago